Skip to content
healthcare.dev
Get a free key

Tazarotene

NDC 73473-309, Tazarotene, gel, from Solaris Pharma Corporation.

Product NDC
73473-309
Status
Listed
Labeler
Solaris Pharma Corporation
Dosage form
GEL
Route
CUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213644
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73473-309 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAZAROTENE.5 mg/g

Pharmacologic classes

Retinoid [EPC]; Retinoids [CS]

Package NDCNDC-11Package
73473-309-10734730309101 TUBE in 1 CARTON (73473-309-10) / 100 g in 1 TUBE
73473-309-30734730309301 TUBE in 1 CARTON (73473-309-30) / 30 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f1c98c4a-f101-4f3c-851a-39c827415c46

  • NADAC price for package 73473030930

    GET /v1/drugs/nadac/73473030930

Use it

Look up 73473-309 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73473-309 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73473-309. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.